£37.01

Humana Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

3882053

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£37 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£76.77 £33.03 £42.58 £52.12 £61.66 £71.20 £80.75 12 March 2026 03 April 2026 25 April 2026 17 May 2026 09 June 2026

Price Distribution

Price distribution over 90 days • 5 price levels

Days at Price
Current Price
21 days · current 14 days 15 days 13 days 27 days 0 7 14 20 27 £37 £45 £62 £66 £77 Days at Price

Price Analysis

Most common price: £77 (27 days, 30.0%)

Price range: £37 - £77

Price levels: 5 different prices over 90 days

Description

Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients' immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells.

Product Specifications

Brand
Humana
Model
3882053
Format
hardcover
Domain
Amazon UK
Release Date
24 November 2003
Listed Since
05 February 2007

Barcode

No barcode data available

Similar Products You Might Like

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)
96% match

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

Humana

£107.98 29 May 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
85% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£108.92 10 Jun 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
85% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.46 31 May 2026
Experimental and Applied Immunotherapy
84% match

Experimental and Applied Immunotherapy

Humana

£140.31 04 May 2026
Experimental and Applied Immunotherapy
84% match

Experimental and Applied Immunotherapy

Humana

£118.30 04 Jun 2026
Brain Tumor Immunotherapy
82% match

Brain Tumor Immunotherapy

Humana

£129.72 03 Jun 2026
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
82% match

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Humana

£103.24 25 May 2026
Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)
82% match

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Humana

£107.98 01 Jun 2026
Cancer Immunotherapy: Paradigms, Practice and Promise
81% match

Cancer Immunotherapy: Paradigms, Practice and Promise

Springer

£108.92 30 May 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
81% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£179.99 31 May 2026
Cancer Immunology: 30 (Immunology and Medicine, 30)
81% match

Cancer Immunology: 30 (Immunology and Medicine, 30)

Springer

£113.76 05 Jun 2026
Chemokines and Cancer (Contemporary Cancer Research)
81% match

Chemokines and Cancer (Contemporary Cancer Research)

Humana

£120.92 31 May 2026
81% match

Hypoxia-induced Tumor Heterogeneity and Immune Evasion: Clinical Interventions (Novel approaches to overcome cancer resistance to conventional therapies)

Academic Press

£145.99 20 May 2026
Immunotherapy for Gastrointestinal Cancer
80% match

Immunotherapy for Gastrointestinal Cancer

Springer

£99.03 05 Jun 2026
Cancer Gene Therapy (Contemporary Cancer Research)
80% match

Cancer Gene Therapy (Contemporary Cancer Research)

Humana

£146.46 31 May 2026
Immunosuppression and Human Malignancy (Contemporary Immunology)
80% match

Immunosuppression and Human Malignancy (Contemporary Immunology)

Humana

£74.80 29 May 2026
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
80% match

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Springer

£145.54 21 May 2026
Patient Surveillance After Cancer Treatment (Current Clinical Oncology)
80% match

Patient Surveillance After Cancer Treatment (Current Clinical Oncology)

Humana

£141.51 05 Jun 2026
Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development)
79% match

Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£145.23 01 Jun 2026
Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)
79% match

Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)

Humana

£69.34 24 May 2026
Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins (Cancer Drug Discovery and Development)
79% match

Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins (Cancer Drug Discovery and Development)

Humana

£45.68 31 May 2026
Cancer Immunoediting And Immune Escape: Tumor Surveillance, Equilibrium and Evasion, From Molecular Mechanisms to Checkpoint Therapy for Medical Students and Oncologists
79% match

Cancer Immunoediting And Immune Escape: Tumor Surveillance, Equilibrium and Evasion, From Molecular Mechanisms to Checkpoint Therapy for Medical Students and Oncologists

£180.12 28 May 2026
Immuno-Oncology: From Bench to Bedside
79% match

Immuno-Oncology: From Bench to Bedside

CREATESPACE

£82.80 08 Jun 2026
Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)
79% match

Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)

Springer

£113.76 21 May 2026